NEUROGESX, INC. (DELAWARE) (NGSX1)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Employees:
2215 BRIDGEPOINTE PARKWAY, SUITE 200, SAN MATEO, CA 94404
650-358-3300

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

N/A

Data derived from most recent annual or quarterly report
Market Cap 133.32 Thousand Shares Outstanding33.33 Million Avg 30-day Volume 42.876 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.11
Price to Revenue0.5921 Debt to Equity-0.8803 EBITDA-15.841 Million
Price to Book Value0.0 Operating Margin-155.5104 Enterprise Value62.465 Million
Current Ratio1.045 EPS Growth0 Quick Ratio0.97
1 Yr BETA -2.935 52-week High/Low 0.0 / Profit Margin-259.6634
Operating Cash Flow Growth34.1426 Altman Z-Score-25.2216 Free Cash Flow to Firm 0
View SEC Filings from NGSX1 instead.

View recent insider trading info

Funds Holding NGSX1 (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding NGSX1 BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MARTELL RON PRESIDENT AND CEO

  • Officer
25,000 2013-01-01 0

GHIGLIERI STEPHEN F EXEC. V.P., COO & CFO

  • Officer
86,293 2012-12-01 0

PEROUTKA STEPHEN J VICE PRESIDENT AND CMO

  • Officer
18,750 2012-11-09 0

MARKELS MICHAEL SENIOR VP,COMMERCIAL & BUS DEV

  • Officer
71,206 2012-09-01 0

LYONS GARY A

  • Director
0 2012-06-07 0

NELSEN ROBERT

  • Director
  • 10% Owner
0 2012-06-07 0

GOODWIN BRADFORD S

  • Director
0 2012-06-07 0

NELSON STEVEN H

  • Director
0 2012-06-07 0

KURTZ NEIL M

  • Director
0 2012-06-07 0

ORWIN JOHN A

  • Director
0 2012-06-07 0

BIENAIME JEAN JACQUES

  • Director
0 2012-02-07 0

DITONNO ANTHONY A PRESIDENT & CEO

  • Officer
  • Director
107,283 2011-12-12 0

TOBIAS JEFFREY K CMO, EVP RESEARCH & DEVE

  • Officer
4,999 2011-09-16 0

ARKIN MOSHE

M. ARKIN (1999) LTD.

  • 10% Owner
  • ALSO MEMBER OF 10% OWNER GROUPMEMBER OF 10% OWNER GROUP
No longer subject to file 2011-08-09 0

BREEN DORON

SPHERA FUNDS MANAGEMENT LTD.

MOR ISRAEL

SENATOR RON

  • MEMBER OF 10% OWNER GROUPMEMBER OF 10% OWNER GROUPMEMBER OF 10% OWNER GROUPMEMBER OF 10% OWNER GROUP
No longer subject to file 2011-08-09 0

ARCH VENTURE FUND V LP

ARCH VENTURE PARTNERS V LP

ARCH VENTURE PARTNERS V LLC

CRANDELL KEITH

BYBEE CLINTON

LAZARUS STEVEN

NELSEN ROBERT

  • Director
  • 10% Owner
5,059,870 2011-07-21 0

BLEY KEITH R SVP, NONCLINICAL R & D

  • Officer
0 2011-02-03 0

RINNE SUSAN P VICE PRESIDENT, REGULATORY

  • Officer
0 2011-02-03 0

KAWAHATA RUSSELL T VP, PHARMACEUTICAL SCIENCE

  • Officer
0 2011-02-03 0

ARKIN MOSHE

  • 10% Owner
  • ALSO MEMBER OF 10% OWNER GROUP
2,648,107 2010-09-09 0

SVLSF IV, LLC

SV LIFE SCIENCES FUND IV LP

SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS L P

SV LIFE SCIENCES FUND IV (GP), L.P.

  • 10% Owner
61,324 2010-05-03 0

FLYNN JAMES E

DEERFIELD CAPITAL LP

DEERFIELD SPECIAL SITUATIONS FUND, L.P.

DEERFIELD MANAGEMENT CO /NY

DEERFIELD SPECIAL SITUATIONS FUND INTERNATIONAL LTD

  • 10% Owner
  • POSSIBLE MEMBER OF 10% GROUP
No longer subject to file 2009-07-13 0

PEACOCK BRUCE

  • Director
0 2009-05-28 0

HARDER KAREN J SVP, REG AFFAIRS

  • Officer
10,000 2007-10-02 0

MARDUEL ALIX

  • Director
  • 10% Owner
5,000 2007-06-05 0

TURNER DANIEL K III

  • Director
5,000 2007-06-05 0

ARCH VENTURE FUND V LP

ARCH V ENTREPRENEURS FUND LP

HEALTHCARE FOCUS FUND LP

ARCH VENTURE PARTNERS V LP

ARCH VENTURE PARTNERS V LLC

CRANDELL KEITH

BYBEE CLINTON

LAZARUS STEVEN

  • 10% Owner
2,531,328 2007-05-07 0

ARCH VENTURE FUND V LP

ARCH VENTURE PARTNERS V LP

ARCH VENTURE PARTNERS V LLC

CRANDELL KEITH

BYBEE CLINTON

LAZARUS STEVEN

  • 10% Owner
227,000 2007-05-02 0

PACVEN WALDEN MANAGEMENT V CO. LTD.

PACVEN WALDEN VENTURES V LP

PACVEN WALDEN VENTURES PARALLEL V-A C.V.

PACVEN WALDEN VENTURES PARALLEL V-B C.V.

PACVEN WALDEN VENTURES V QP ASSOCIATES FUND LP

PACVEN WALDEN VENTURES V ASSOCIATES FUND LP

TAN LIP BU

KAU ANDREW

COLEMAN MARY

  • 10% Owner
  • SEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKS
0 2007-05-01 0

IVCIC-WALDEN MANAGEMENT CO LTD.

INTERNATIONAL VENTURE CAPITAL INVESTMENT III CORP

ASIAN VENTURE CAPITAL INVESTMENT CORP

INTERNATIONAL VENTURE CAPITAL INVESTMENT CORP

TAN LIP BU

LOO HOCK VOON

  • SEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKS
0 2007-05-01 0

WALDEN INTERNATIONAL SINGAPORE PTE LTD.

SEED VENTURES III PTE LTD.

TAN LIP BU

LOO HOCK VOON

  • SEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKS
0 2007-05-01 0

MARDUEL ALIX

ALTA CALIFORNIA MANAGEMENT PARTNERS II LLC

ALTA CALIFORNIA MANAGEMENT PARTNERS II, LLC -- NEW POOL

ALTA CALIFORNIA PARTNERS II LP

ALTA CALIFORNIA PARTNERS II, L.P. -- NEW POOL

ALTA EMBARCADERO PARTNERS II LLC

DELEAGE JEAN

GRUENER GARRETT

JANNEY DANIEL

NOHRA GUY P

  • Director
  • 10% Owner
0 2007-05-01 0

MONTREUX EQUITY PARTNERS II SBIC LP

MONTREUX EQUITY MANAGEMENT II SBIC LLC

PALEFSKY HOWARD D

TURNER DANIEL K III

CHAPEKAR MANISH

SAVARESE JOHN

  • Director
  • SEE GENERAL REMARKSSEE GENERAL REMARKSSEE GENERAL REMARKSSEE GENERAL REMARKSSEE GENERAL REMARKSSEE GENERAL REMARKS
0 2007-05-01 0

MONTREUX EQUITY MANAGMENT III SBIC

TURNER DANIEL K III

PALEFSKY HOWARD D

CHAPEKAR MANISH

SAVARESE JOHN

  • Director
  • SEE GENERAL REMARKSSEE GENERAL REMARKSSEE GENERAL REMARKSSEE GENERAL REMARKSSEE GENERAL REMARKS
0 2007-05-01 0

ALTA BIOPHARMA MANAGEMENT III LLC

ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG

ALTA BIOPHARMA PARTNERS III LP

ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC

CHAMPSI FARAH

HURWITZ EDWARD

PENHOET EDWARD

  • 10% Owner
0 2007-05-01 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments